JOIN OUR TALENT COMMUNITY
Receive updates on events and new opportunities to join our team!
It is an exciting week for NeoGenomics. We are honored to officially welcome Mark Mallon as CEO of NeoGenomics.
NeoGenomics is a true global leader in oncology diagnostics and is a critical part of cancer drug development. At Neo, we save lives by improving patient care. This is our Common Purpose, and we take this responsibility seriously because our patients' lives depend on us.
As we continue to build on our outstanding foundation, we are confident that Mark Mallon is the right person to lead NeoGenomics as we bring our Vision to life of becoming the world’s leading cancer testing and information company.
Most importantly, Mark truly embodies our core values of quality, integrity, accountability, teamwork, and innovation.
“I feel honored to work alongside the talented team at NeoGenomics and contribute to making our vision a reality,” said Mark. “I am passionate about connecting the right patients to the right treatment at the right time, and together, we will work every day to save lives.”
Please join us in welcoming Mark Mallon to the NeoGenomics family. This is a celebration for our organization, as well as a recognition of the patients for whom it’s our privilege to serve.
We invite you to learn more about Mark.
Interested in a career at NeoGenomics? Browse job opportunities, and read more about the benefits at Neo. You can also check us out on Glassdoor and watch a video about the #LifeAtNeo.
Receive updates on events and new opportunities to join our team!